Knockdown of Toll-like receptors (TLRs) is a novel therapeutic strategy in treating patients with rheumatoid arthritis (RA). We examined the effects of lentiviral vector-mediated delivery of TLR7 short hairpin RNA gene (Lt.shTLR7) on collagen-induced arthritis (CIA). After being immunized on days 0 and 7, Sprague -Dawley rats received intra-articular (i.a.) injection of Lt.shTLR7 or scramble control vector on days 7 and 10. The therapeutic effects were evaluated by measuring ankle circumferences, articular index, and radiographic and histological scores on killing on day 16. Microvessel densities, vascular endothelial growth factor (VEGF) levels, pro-inflammatory cytokine concentrations and T-cell numbers within the synovial tissues were measured. Moreover, VEGF and pro-inflammatory cytokine concentrations in culture supernatants from TLR7-transfected synovial fibroblasts (SFs) stimulated with imiquimod or endogenous ligands were examined. There were significant reduction in ankle circumferences, articular indexes, and radiographic and histological scores. Microvessel densities, VEGF concentrations, interleukin (IL)-1b and IL-6 levels and T-cell densities within synovial tissues were significantly lower. Induction of VEGF, IL-1b and IL-6 production from stimulated SFs was significantly suppressed. Taken together, these data demonstrate the effects of i.a. lentiviral vector-mediated delivery of shTLR7 RNA gene on inhibition of CIA, and implicate the manipulation of TLR7 as a potential therapeutic strategy in RA patients.
INTRODUCTION
Toll-like receptors (TLRs) are a family of membrane proteins that trigger the nuclear factor-kB-dependent and the interferon-regulatory factor-dependent signaling pathways, and activation of TLRs upregulates the expression of costimulatory molecules, the production of reactive nitrogen and oxygen species, pro-inflammatory cytokines, type I interferons, chemokines and matrix metalloproteinase, and the activation of diverse cell populations within the immune system. 1 -3 Notably, the Th1-and Th17-mediated immune responses can be initiated or augmented through the ligation of TLRs with their ligands. 4, 5 However, strong TLR-induced responses might contribute to the induction of autoimmunity and lead to lethal systemic inflammation. 6 Animal experiments have documented the ability of TLR ligands in triggering the onset of arthritis. 7 The classic streptococcal cell wall rat arthritis model is induced by the intraperitoneal injection of streptococcal cell wall containing the peptidoglycan fragment, a TLR2 ligand. 8 More pieces of evidence for sustaining the autoimmunity by TLRs were successfully demonstrated by the reduction of collagen-induced arthritis (CIA) after receiving a TLR-4-specific antagonist, and by the exacerbation of joint inflammation in the SIGIRR/TIR-8 (an inhibitor of TLRs signaling)-knockout mice in both the zymosan-induced arthritis and collagen antibody-induced arthritis models, which suggested that disruption of TLRs signaling could provide an additional clinical therapeutic modality for patients with rheumatoid arthritis (RA). 9, 10 The TLRs have important roles in host defense, and exogenous ligands of TLRs such as DNA and peptidoglycan of bacterial origin have been detected in joint fluid samples from RA patients. 11 It has become apparent that the recognition of self-molecules by TLRs is strongly associated with the pathogenesis of autoimmune diseases and chronic inflammation. 2 Endogenous TLR4 ligands such as heat shock proteins, fibrinogen, high mobility group box 1 protein, fibronectin (extra domain A) and hyaluronan fragments have been identified in inflamed joints. 7, 12 The TLR2 ligand peptidoglycan, TLR3 ligand dsRNA and TLR9 ligand CpG DNA were reported to induce arthritis through intra-articular (i.a.) injection. 13 -15 In addition, systemic administration of lipopolysaccharide, signaling through the TLR4, has been demonstrated to reactivate arthritis in different mouse models. 16, 17 Increased expressions of TLR2 and TLR4 were found in synovial macrophages from RA patients, and enhanced activation by stimulation with TLR ligands were also demonstrated in these cells. 18 Expression of TLRs on B cells were augmented following the stimula-tion of B-cell receptors, and the subsequent ligation of TLRs contributed to the production of rheumatoid factor. 19 Moreover, proinflammatory cytokines, chemokines and matrix metalloproteinases were produced by dendritic cells from rheumatoid joints through the stimulation of TLRs. 20 In addition, stimulation of synovial fibroblasts (SFs) from RA patients with TLR2 or TLR4 ligands significantly induced the expression of receptor activator of nuclear factor-kB ligand, and further promoted the differentiation of monocytes into osteoclasts. 21 Taken together, activation of diverse cell populations within rheumatoid joints such as macrophages, SFs, B cells and dendritic cells by the recognition of microbial products or endogenous ligands can induce the production of pro-inflammatory cytokines, type I interferons, chemokines, matrix metalloproteinases and receptor activator of nuclear factor-kB ligand, resulting in synovial inflammation and osteoclast differentiation, and finally lead to joint destruction in RA patients. Abundant expression levels of TLR7 have been demonstrated immunohistochemically in both the lining and sublining regions of rheumatoid synovium. 20, 22 Therefore, knockdown or inhibition of the TLR7 pathway from the surface or intracellular receptors to downstream signaling molecules could be a novel therapeutic strategy in RA patients.
Lentiviral vectors have been reported to be one of the most powerful and effective integrating vector systems for gene transfer, and proved to result in efficient expression of genes in synovial tissues. 23, 24 The i.a. injection is a simple and efficient method for delivery of genes into the inflamed joints, and a direct genetic modification can take place following such a manipulation. Clinical trials of i.a. gene therapy in RA patients have progressed to phase II and provided the preliminary evidence of efficacy and safety. 25 In this study, the therapeutic effects of i.a. disruption of TLR7 signaling on arthritis were examined by using the delivery of lentiviral vectormediated TLR7 short hairpin RNA (shRNA) gene in a rat CIA model.
RESULTS
Upregulation of TLR7 in synovial lining and sublining SFs of CIA ankle joints Western blots of TLR7 from ankle synovial tissue extracts of naïve (N) and CIA rats (days 11, 14 and 17) are shown in Figure 1a with the densities ratios of TLR7 to b-actin (an internal control). Notably, TLR7 expression reached the peak levels on day 14 (average ratios, 0.043 on day 11, 0.06 on day 14 and 0.035 on day 17). Representative photographs of TLR7 expression in synovial tissues of N and CIA rats are demonstrated on Figure 1b . As the synovial lining cells and the sublining synoviocytes expressed TLR7, the cultured CIASFs were further examined for the TLR7 expression. Expression of TLR7 was increased in CIASFs as compared with N counterparts (Figure 1c , a clear background staining in control sections receiving immunoglobulin G isotype antibodies).
Clinical, radiological and histopathological assessments on the Lt.shTLR7 treatment Figure 2a shows the significant reduction of ankle circumferences and articular indexes in the Lt.shTLR7-treated ankles as compared with the Lt.scramble-injected joints (ankle circumference, Lt.shTLR7 vs Lt.scramble, P¼0.0318; articular index, Lt.shTLR7 vs Lt.scramble, Po0.0001). Representative radiological graphs of rat ankle joints receiving different treatments are demonstrated in Figure 2b , and the mean scores were significantly lower in the Lt.shTLR7-injected ankle as compared with the Lt.scramble-treated joints (Lt.shTLR7 vs Lt.scramble, 1.81 ± 0.16 vs 2.94 ± 0.11, Po0.0001). Histopathological analyses were performed to confirm the results of clinical and radiological examinations (Figure 2c ). The Lt.shTLR7-injected ankles demonstrated relatively less cartilage damage and leukocytes infiltration as compared with ankle joints receiving the Lt.scramble treatment, the mean scores were significantly lower in Lt.shTLR7-treated joints as compared with the scramble vector-injected counterparts (Lt.shTLR7 vs Lt.scramble, 2.06±0.35 vs 4.50±0.29, Po0.0001).
Suppression of microvessel densities and vascular endothelial growth factor (VEGF) levels by in vivo knockdown of TLR7 molecule The reverse transcription-PCR and western blot analyses were performed to elucidate whether an in vivo downregulation of i.a. TLR7 in CIA rats could contribute to the inhibition of arthritis. Both of the mRNA and protein levels from joint extracts were significantly reduced in the Lt.shTLR7-injected ankles as compared with Lt.scramble-treated controls (Figure 3a) . The contribution of TLR7 in arthritis through the promotion of angiogenesis was further elucidated by the calculation of microvessel densities in synovial tissues of CIA joints, and representative pictures are shown in Figure 3b with significantly decreased von Willebrand factor-stained vessel numbers in Lt.shTLR7-treated ankles as compared with Lt.scramble-injected joints. The mean microvessel densities were significantly reduced in Lt.shTLR7-injected joints as compared with Lt.scramble-treated ankles (Figure 3c Figure 3e with a clear dose-dependent effect and the optimal concentration for maximal stimulation at 10 mg ml -1 . The in vitro effect of Lt.shTLR7 transfection on suppression of VEGF production induced by 10 mg ml -1 imiquimod was examined, and the relative percentages of VEGF production were significantly decreased in the Lt.shTLR7-treated CIASFs as compared with the Lt.scrambletransfected controls (Figure 3f , Lt.shTLR7 vs Lt.scramble, 110.9±5.4 vs 206.4 ± 3.1, Po0.0001). Matrix metalloproteinase-9 was shown to initiate and promote new vessel formation in arthritis, and its expression was examined in joint extracts of Lt.shTLR7-and Lt.scramble-injected ankles with lower levels in the former treatment group in comparison with the latter control counterparts (data not shown). 26 Taken together, these data indicate that the production of VEGF within CIA ankle joints could be significantly reduced by knocking down the i.a. expression of TLR7 on CIASFs, which further contributes to the reduction of angiogenesis and suppression of arthritis.
Reduction of pro-inflammatory cytokines production by the Lt.shTLR7 treatment Both of the interleukin (IL)-6 and IL-1b levels were significantly lower in Lt.shTLR7-treated joints as compared with Lt.scramble-injected ankles ( Figure 4a , IL-6, Lt.shTLR7 vs Lt.scramble, 95.40 ± 29.01 vs 271.8±48.62, P¼0.0109; Figure 4b , IL-1b, Lt.shTLR7 vs Lt.scramble, 227.6 ± 43.23 vs 543.7 ± 103.0, P¼0.00178). No statistically significant difference in tumor necrosis factor (TNF)-a concentrations was found (data not shown). Furthermore, we performed the in vitro experiments to examine the influence of TLR7 ligation with imiquimod on induction of pro-inflammatory cytokine production from CIASFs, and a dose-dependent effect on IL-6 production is demonstrated on Figure 4c . The relative percentages of IL-6 production from CIASFs stimulated with imiquimod were significantly reduced by the Lt.shTLR7 transfection as compared with the Lt.scramble treatment There was no reduction of IL-1b production by the Lt.shTLR7 transfection, and TNF-a concentrations in culture supernatants were under detection limit by the enzyme-linked immunosorbant assay (ELISA) method (data not shown). Therefore, IL-6 production could be significantly inhibited by knocking down the i.a. expression of TLR7 on CIASFs, which further contributes to the reduction of arthritis. In addition to the synthetic ligand imiquimod, the effects of endogenous TLR7 ligands on the production of proinflammatory cytokines from CIASFs were examined. RNA has been demonstrated to be released from necrotic synovial fluid cells within inflamed joints. 2, 12 We pre-treated joint extracts from CIA ankles with RNAse or chloroquine before adding to the cultured CIASFs. Figures  5a and b show that the addition of joint extracts from CIA rats significantly upregulated the production of IL-6 and IL-1b (IL-6, 1492±164 vs 4912±686, P¼0.0029; IL-1b, pgml -1 , 35.6±8.9 vs 205.1 ± 14.5, P¼0.0003), and further treatment with benzonase or chloroquine significantly suppressed the production of IL-6 and IL-1b (benzonase, IL-6, 2205 ± 318, P¼0.0117, IL-1b, 121.9 ± 7.3, P¼0.0022; chloroquine, IL-6, 1558±92, P¼0.0029, IL-1b, 148±14, P¼0.0301). Treatment with benzonase or chloroquine also significantly inhibited the production of TNF-a (Figure 5c , benzonase, 60.6 ± 8.7 vs 34.0 ± 2.1, P¼0.0186; chloroquine, 30.5 ± 4.6, P¼0.0382). Thus, in inflamed milieu of CIA joints, RNAs released from synovial cells could serve as corresponding endogenous ligands to the TLR7, further induce the production of pro-inflammatory cytokines and result in sustention and progression of arthritis.
DISCUSSION
Abundant expression of TLR7 in the lining and sublining regions have been identified in synovial components of RA patients, and our studies clearly demonstrate significant TLR7 expression after the induction of arthritis in CIA rats. 20, 22 Significant intracellular TLR7 staining on CIASFs appears to be responsible for TLR7 expression in lining and sublining synovial cells of ankle joints, and therefore we performed the in vivo experiments using lentiviral vectors expressing TLR7 shRNA gene to examine whether knockdown of TLR7 molecule could suppress the rat arthritis. The efficacy of silencing i.a. TLR7 expression by lentivirus-mediated gene transfer was verified by using clinical (articular indexes and ankle circumferences) and radiological examinations, and further confirmed by histopathological analyses. Biological inhibitors of arthritis such as TNF-a blockades are currently being used in the treatment of RA patients; however, these therapies do not cure the disease and are associated with an increased risk of infection. As the variety of TLR ligands released in one particular autoimmune disease could be limited, targeting certain TLRs could be more specific without global impairment on the immune system. 2
TLRs could represent a better set of targets than pro-inflammatory cytokines because of their earlier appearance in the signaling transduction pathway and more potent activities. 27, 28 As shown in the Figure 5 and previous reports, endogenous ligands of TLRs derived from sustaining inflammation could lead to the progression of disease process in the autoimmune-related arthritis. 2, 7, 12, 28 Targeting TLRs might bring about the remission of arthritis, and miscellaneous approaches could be exploited. 27, 28 Neutralizing antibodies to these molecules are only possible for those on the cell surface such as TLR2 and TLR4, and there is difficulty in predicting the efficacy of small molecule antagonists because of their off-target effects. The downstream kinases on the TLR signaling pathway could be amenable to inhibition; however, an inhibitor might block multiple TLRs and give rise to unwanted side effects. Therefore, novel technologies are needed in targeting nucleic acid-recognizing TLRs expressed on intracellular endosomal membrane. Chloroquine has been used in clinical therapy of RA, and their mechanisms of action are known to be the inhibition of TLR7, 8 and 9 by increasing the pH of endosomes with further interference of the downstream signaling. 28 Several suppressive oligodeoxynucleotides that block the TLR7/9-mediated signaling pathway have been shown to reduce the release of TNF-a from dendritic cells, the upregulation of major histocompatibility complex class II and the expression of costimulatory molecules on these cells. 29 The RNA interference with small-interfering RNA to exploit an intracellular antiviral pathway by silencing the specific genes has been tried as the TLRs antagonism strategy. 30 This study is an in vivo approach to treat CIA rats by using the lentiviral vector-mediated delivery of shRNA gene to knock down TLR7, and demonstrates a feasibility of targeting i.a. TLR molecules as a novel strategy in treating the autoimmune-related arthritis.
Colocalization of IL-12 and IL-18 with TLRs were demonstrated in synovial tissues from rheumatoid joints, and nucleic acid-based agonists of TLRs were reported to induce a Th1-mediated immune response. 4, 31, 32 Our results reveal significantly lower in vivo and in vitro amounts of pro-inflammatory cytokines in the Lt.shTLR7-injected joints and Lt.shTLR7-transduced CIASFs, respectively. Furthermore, i.a. knockdown of TLR7 significantly reduces the in vivo microvessel densities and VEGF concentrations in the synovial tissues of CIA rats, and transduction of Lt.shTLR7 also significantly inhibits the in vitro VEGF production from CIASFs on the ligation of TLR7 with its ligands. Notably, upregulation of VEGF production involving the synergy between TLR7 and adenosine A receptors has been identified, and our findings could further support the involvement of TLR7 in the angiogenic process possibly through the augmentation of VEGF signal transduction pathway. 33 Finally, T-cell numbers within the ankle joints of CIA rats are reduced by i.a. knockdown of TLR7 molecule (Lt.shTLR7 vs Lt.scramble, 384.3 ± 13.9 vs 979.3 ± 14.8, Po0.001). IP-10, a Th1-related chemokine, was reported to be induced from dermal fibroblasts on ligation of TLRs with different ligands, and derived from plasmacytoid dendritic cells in response to the stimulation with TLR7 agonist. 34, 35 Indeed, IP-10 is observed on the ligation of CIASFs with imiquimod, a synthetic TLR7 ligand in our experiment (data not shown). Thus, silencing the TLR7 expression on SFs could reduce the production of Th1-attracting chemokines such as IP-10, and result in the decreased influx of activated Th1 cells into the inflamed joints of autoimmunerelated arthritis.
In conclusion, by using a novel technological approach, that is, knockdown of TLR7 molecule through the lentiviral vector-mediated delivery of shRNA gene, we demonstrate for the first time in the CIA model that silencing i.a. TLR7 signaling pathway could suppress rat arthritis. These findings implicate the manipulation of TLR7 as a potential therapeutic strategy in RA patients.
MATERIALS AND METHODS

Construction of lentiviral vectors expressing TLR7 shRNA
To construct shRNA targeting TLR7, we selected heteroduplexes according to the pSuper formula (Oligoengine, Seattle, WA, USA) to target different locations of this gene according to the sequence of rat TLR7 gene (GenBank accession number NM_001097582). 24 The heteroduplexes supplied as 60 nucleotides oligodeoxynucleotides were annealed and inserted downstream of the H1 promoter into pSuper vector (Oligoengine) at the BglII and HindIII sites to generate pSuper/shTLR7. After the screening, the shRNA expression cassette containing the sequences for H1 promoter and shTLR7 (sense 5¢-GATC CCCCAACAACCGGCTTGATTTATTCAAGAGATAAATCAAGCCGGTTGTTTT TA-3¢ and antisense 5¢-AGCTTAAAAACAACAACCGGCTTGATTTATCTCTT GAATAAATCAAGCCGGTTGTTGGGG-3¢) was recovered from the pSuper/ shTLR7 plasmid by EcoRI and ClaI digestion, and further ligated by T4 DNA ligase (Invitrogen, Carlsbad, CA, USA) into the same site of lentiviral transfer plasmid pLVTHM (a kind gift from Dr D Trono, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland), resulting in the pLVTHM/shTLR7 (Lt.shTLR7) plasmid expressing both TLR7 shRNA and green fluorescent protein (GFP). 36 In addition, the lentiviral vectors carrying the irrelevant oligodeoxynucleotides that were unable to suppress the expression of TLR7 (Lt.scramble, a scramble vector) were used as the control vectors for the following experiments.
Screening of TLR7 shRNA, production of lentiviral particles and determination of viral titers Sub-confluent 293T cells (10 5 cells per well in six-well plates) were co-transfected with 1.5 mg of pSuper control plasmid, pSuper/scramble vector (negative control), pSuper/shGFP (positive control), or pSuper/shTLR7 and 1.5 mg of pcDNA3.1(+)/TLR7-IRES-GFP by polyethylenimine (25 kDa, 0.45 mg ml -1 , pH 7.0, Sigma, St Louis, MO, USA). After culture in 2% cosmic calf serum (Hyclone, Logan, UT, USA) for 48 h, the degree of suppression of GFP expression was analyzed by flow cytometry using a FACScan (Becton Dickinson, San Jose, CA, USA) to evaluate the efficacy of different pSuper/ shTLR7 plasmids in knocking down the TLR7 expression. The recombinant lentiviral vectors were produced by transient transfection of 293T cells according to the standard protocols. 37 In brief, sub-confluent 293T cells were co-transfected with Lt.shTLR7 (transfer plasmid), psPAX2 (packaging plasmid) and pMD2.G (envelope plasmid) by calcium phosphate precipitation method. The lentiviral vectors were harvested 48 h after the transfection and concentrated by ultracentrifugation. TE671 cells (a human rhabdomyosarcoma cell line) were seeded at 2Â10 5 cells per well in six-well plates and incubated overnight at 37 1C in a CO 2 incubator. Ten-fold serial dilution of lentiviral vectors carrying the GFP reporter gene was made in the serum-free medium. TE671 cells were infected with 1 ml of lentiviruses in the presence of polybrene (8 mg ml -1 , Sigma). After 6 to 8 h, the virus-containing medium was removed and the fresh medium was added, and these cells were allowed to grow for an additional 2 to 3 days. TE671 cells were collected and then subjected to flow cytometric analysis (FACScan, Becton Dickinson). The virus titer based on transduction unit (TU) was calculated by GFP-positive cells (%)Â(2Â10 5 )Âtimes of dilution. Physical titers of lentiviruses expressed as viral particles were also determined by analysis of the virus-associated p24 core protein (QuickTiter Lentivirus titer kit, Cell Biolabs, San Diego, CA, USA). On the basis of the titers of TU and viral particle for our recombinant lentiviruses, 2000 viral particle approximately equals to 1 TU. 24 The efficacy of knocking down the TLR7 expression was confirmed by the transfection of circulating mononuclear cells from CIA rats (day 12 after the first immunization) with the Lt.shTLR7 vector or scramble control at the multiplicities of infection of 10 for 48 h with a 91.3% reduction of expression levels by using the western blot analysis (ratio of TLR7 to b-actin, Lt.shTLR7 vs Lt.scramble, 0.59 vs 6.81).
Induction and clinical and radiological evaluation of rat CIA Sprague -Dawley rats (male, 7B8 weeks of age) were obtained from the Laboratory Animal Center in Medical College of National Cheng Kung University. The experiments were approved by the Laboratory Animal Care and Use Committee of the National Cheng Kung University. Rats were immunized on day 0 and boosted on day 7 with intradermal injection of bovine type II collagen in Freund's adjuvant (Sigma) as described previously. 24,38 -40 After being immunized with type II collagen on days 0 and 7, rats received i.a. injection of 3Â10 5 TU Lt.shTLR7 into the right ankles and 3Â10 5 TU Lt.scramble vectors into the left ankles on days 7 and 10. The ankle joints were held in 15 to 201 of plantar flexion and a 31-gauge needle on the plastic syringe was inserted anterolaterally at the ankle joint line about 1 to 2 mm distal to the lateral malleolus. 41 The ankle circumferences and articular indexes were evaluated on days 7, 10, 12, 14 and 16. The articular indexes were scored from 0 to 4 (0¼no swelling or erythema, 1¼slight swelling and/or erythema, 2¼low-to-moderate edema, 3¼pronounced edema with limited joint usage and 4¼excess edema with joint rigidity). 42 Ankle joints were removed and then received radiographic examinations on killing on day 16 as described previously. 24,38 -40 Histopathological assessment and immunohistochemical study of CIA joints Rat ankles were resected en bloc and fixed in 4% buffered formalin on killing on day 16. After further decalcification, the joints were cut on the sagittal plane through the center of the joint line, embedded in paraffin, sectioned and stained with hematoxylin and eosin. The histological pictures were evaluated and scored semiquantitatively as described previously. 24,38 -40 The presence of synovial hyperplasia, cartilage erosion and inflammatory infiltrates with leukocytes was evaluated and scored semiquantitatively on a scale of 0 to 2 for each item (0¼absent and normal, 1¼mild and slight, 2¼severe and pronounced), where the maximum score an ankle joint could receive was 6. After deparaffinization and rehydration, the paraffin-embedded synovial tissue sections (5 mm) were stained with anti-rat TLR7 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-rat von Willebrand factor antibody (DAKO, Carpinteria, CA, USA) or anti-rat CD3 antibody (BD Bioscience, San Jose, CA, USA). The amino-9-ethylcarbazole substrate kit (Zymed Laboratories, South San Francisco, CA, USA) was used as the chromogen. Small vessels consisting of von Willebrand factor-positive endothelial cells were counted for evaluation of microvessel density. Stained blood vessels and the CD3-positive cells were counted in three blindly chosen random fields at Â200 magnifications and the average vessel numbers and mean CD3-positive cells per field in each slide from different treatment group were calculated. Freshly prepared synovial tissues from ankle joints of CIA rats were cultured as described previously. 39 After the adherence for 48 h, non-adherent cells were removed and adherent cells were cultured continuously until confluence. The CIASFs became a homogeneous population after 44 passages, and the immunohistochemical staining of TLR7 was performed in these cultured SFs. Furthermore, we confirmed the fibroblasts to be the synovial but not epithelial origin by the immunobloting analysis (expression of the specific SF marker cadherin-11, and not the epithelial cell marker, E-cadherin).
ELISA and western blot analyses
The concentrations of TNF-a, IL-1b, IL-6 and VEGF in joint homogenates and culture supernatants were determined by using commercial rat ELISA kits according to the manufacturer's protocol (R&D, Minneapolis, MN, USA). The total protein concentrations were determined by Bradford's methods with a commercially available protein assay kit (Bio-Rad, Hercules, CA, USA). Cultured cells after being harvested, synovial tissues from CIA rats receiving the Lt.shTLR7 or Lt.scramble injection for 48 h (each group pooled from three individual ankles), or those from CIA joints without treatment on day 11, 14 or 17 were further treated with the RIPA lysis buffer for 30 min (50 mM Tris-HCl at pH 7.4, 0.5% sodium deoxycholate, 150 mM NaCl, 1% NP-40, 2 mM ethyleneglycol tetraacetic acid, 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, 0.001% aprotinin, 0.001% leupeptin and 1 mM EDTA). The cell lysates were then subjected to centrifuge at 13 000 r.p.m. for 10 min, and the supernatants were collected. The ankle joints were cut, skinned and further homogenized in 1 ml of RIPA lysis buffer containing a protease inhibitor cocktail (Halt Protease Inhibitor Cocktail, Pierce, Rockford, IL, USA). 38 The cell lysates or joint tissue extracts were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the proteins were then transferred to a PVDF membrane (Amersham, Uppsala, Sweden). The membrane was further incubated with rabbit anti-rat TLR7 antibodies (Santa Cruz Biotechnology), followed by peroxidase-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch, West Grove, PA, USA). The blot was then developed with the ECL plus system (Amersham Pharmacia Biotech, Little Chalfont, UK) and further analyzed with the Biospectrum imaging system (UVP, Upland, CA, USA) for chemiluminescence detection. The signal intensity was quantitated by the densitometric analysis.
Pro-inflammatory cytokines and VEGF assays on culture supernatants of CIASFs
The CIASFs cultured in 24-well plates with 3Â10 4 cells per well were stimulated with different concentrations of imiquimod (Sigma), a synthetic TLR7 ligand, for 16 h. The culture supernatants were then harvested for measuring the levels of pro-inflammatory cytokines and VEGF by ELISA. The influence of TLR7 knockdown on the production of pro-inflammatory cytokines and VEGF induced by the stimulation with imiquimod was studied by the following experiments. The CIASFs were infected with Lt.shTLR7 or Lt.scramble at multiplicities of infection of 10 for pro-inflammatory cytokines and at multiplicities of infection of 20 for VEGF for 48 h. The infected cells (3Â10 4 cells per well) were further stimulated with 10 mg ml -1 imiquimod for 24 h. The culture supernatants were then harvested for measurement of pro-inflammatory cytokines and VEGF levels by ELISA. Finally, the effect of endogenous TLR7 ligands on the production of pro-inflammatory cytokines by SFs was examined. The joint extracts samples pooled from synovial tissues of CIA rats on day 15 (as the endogenous ligands of TLR7) were used in the following experiments. These samples were further treated with an RNAse (benzonase, Sigma), or an inhibitor of acidification of endosome (chloroquine, Sigma). The CIASFs cultured in 24-well plates were incubated with benzonase-or chloroquinetreated or with non-treated joint extracts (25 mg) for 24 h, and culture supernatants were harvested for assessing pro-inflammatory cytokines.
Zymographic and reverse transcription-PCR analyses
Joint extracts from killed rat ankles were electrophoresed on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 0.2 % gelatin. After removal of sodium dodecyl sulfate with 1% Triton X-100 for 1 h, the gels were incubated in 40 mM Tris-HCl (pH 7.5) containing 10 mM CaCl 2 , then stained with 7.5% acetic acid/10% propanol-2 containing 0.5% Coomassive Brilliant Blue G250, and further destained in water as described previously. 39 The TLR7 expression in the synovial tissues of ankles of CIA rats receiving Lt.shTLR7 or Lt.scramble treatment for 48 h were examined by the reverse transcription-PCR. Total RNA was isolated by the TRIzol reagent (Invitrogen). The REVERSE-IT first-strand synthesis kit (ABgene, Epsom, UK) was used for the complementary DNA synthesis. The CIASFs were stimulated with different concentrations of imiquimod for 16 h, and reverse transcription-PCR of rat interferon-inducible protein-10 (IP-10) was performed for the harvested RNA from these cells by using the primers forward 5¢-TTCCTGCAAGTC-TATCCTGTCCGC-3¢ and reverse 5¢-TTTGCCATCTCACCTGGACTGC-3¢. The forward and reverse PCR primers of rat TLR7 were 5¢-AGCTCTGTTCTCCTCCACCA-3¢ and 5¢-CATGGGTGTTTGTGCTATCG-3¢, respectively 
Statistical analyses
Data are expressed as the mean ± s.e.m. Differences in ankle circumferences or articular indexes between Lt.shTLR7 and Lt.scramble treatment groups were compared with the repeated-measures analysis of variance by using a SAS software (version 9.1, GLM program; SAS Institute, Cary, NC, USA). Differences in radiological and histological scores, microvessel densities, pro-inflammatory cytokine levels, VEGF concentrations and relative percentages of proinflammatory cytokine or VEGF between two treatment groups were compared with Student's t-test. P-values o0.05 were considered significant.
